Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Fibrosis-Modulating Potential of Metformin and Pirfenidone in Oral Submucous Fibrosis: Molecular Mechanisms to Clinical Applications

NCT06871904 is registered in ClinicalTrials.gov with Ziauddin University as lead sponsor.

NCT NCT06871904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06871904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Fibrosis-Modulating Potential of Metformin and Pirfenidone in Oral Submucous Fibrosis: Molecular Mechanisms to Clinical Applications
Lead sponsor
Ziauddin University
Phase
Phase 1/2
Overall status
Completed
Start date
April 7, 2025
Completion date
December 30, 2025
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral submucous fibrosis